Short answer
Medtronic (MDT) filed its Q4 2025 10-Q quarterly report on Nov 25, 2025 for the quarter ended Oct 24, 2025. Quarterly revenue was $9.0B (up 6.6% year over year) with net income of $1.4B.
Q4 2025 key financials · XBRL
- Revenue
- $9.0B
- +6.6% YoY · +4.5% QoQ
- Net income
- $1.4B
- +8.2% YoY · +32.1% QoQ
- Operating margin
- 18.8%
- EPS (diluted)
- $1.06
- +7.1% YoY · +30.9% QoQ
Source: XBRL data from the Medtronic (MDT) Q4 2025 10-Q on SEC EDGAR. USD.
Medtronic Q4 2025 10-Q analysis
AI summary of MD&A and risk factor updates
Risk Factors
- No new risk factors added this quarter; risks consistent with prior 10-K filing
- Most material update: impact of armed conflicts on international operations highlighted due to geopolitical tensions
- Regulatory risk: delays in regulatory approvals and adverse regulatory actions continue as key compliance challenges
- Market risk: increasing pricing pressure and decreasing selling prices affecting near-term revenue growth potential
- Financial risk: liquidity shortfalls and fluctuations in currency exchange rates remain critical financial exposures
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Medtronic quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.